img

Global Eye Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Eye Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Eye Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Eye Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Glaucoma and Retinal Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Eye Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Eye Drug key manufacturers include Pfizer, Novartis, bausch Lomb, Laboratoire Riva, Jamp Pharma, Fresenius, Teva Pharmaceutical?, SANDOZ and Greenstone, etc. Pfizer, Novartis, bausch Lomb are top 3 players and held % sales share in total in 2022.
Eye Drug can be divided into Drops and Tablet & Capsule, etc. Drops is the mainstream product in the market, accounting for % sales share globally in 2022.
Eye Drug is widely used in various fields, such as Glaucoma, Retinal Disease, Bacterial?Infection and Other, etc. Glaucoma provides greatest supports to the Eye Drug industry development. In 2022, global % sales of Eye Drug went into Glaucoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Eye Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma
Segment by Type
Drops
Tablet & Capsule

Segment by Application


Glaucoma
Retinal Disease
Bacterial?Infection
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Eye Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Eye Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Eye Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Eye Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Eye Drug introduction, etc. Eye Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Eye Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Eye Drug Market Overview
1.1 Eye Drug Product Overview
1.2 Eye Drug Market Segment by Type
1.2.1 Drops
1.2.2 Tablet & Capsule
1.3 Global Eye Drug Market Size by Type
1.3.1 Global Eye Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Eye Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Eye Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Eye Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Eye Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Eye Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Eye Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Eye Drug Sales Breakdown by Type (2018-2024)
2 Global Eye Drug Market Competition by Company
2.1 Global Top Players by Eye Drug Sales (2018-2024)
2.2 Global Top Players by Eye Drug Revenue (2018-2024)
2.3 Global Top Players by Eye Drug Price (2018-2024)
2.4 Global Top Manufacturers Eye Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Eye Drug Market Competitive Situation and Trends
2.5.1 Eye Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Eye Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eye Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Eye Drug Market
2.8 Key Manufacturers Eye Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Eye Drug Status and Outlook by Region
3.1 Global Eye Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Eye Drug Historic Market Size by Region
3.2.1 Global Eye Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Eye Drug Sales in Value by Region (2018-2024)
3.2.3 Global Eye Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Eye Drug Forecasted Market Size by Region
3.3.1 Global Eye Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Eye Drug Sales in Value by Region (2024-2034)
3.3.3 Global Eye Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Eye Drug by Application
4.1 Eye Drug Market Segment by Application
4.1.1 Glaucoma
4.1.2 Retinal Disease
4.1.3 Bacterial?Infection
4.1.4 Other
4.2 Global Eye Drug Market Size by Application
4.2.1 Global Eye Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Eye Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Eye Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Eye Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Eye Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Eye Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Eye Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Eye Drug Sales Breakdown by Application (2018-2024)
5 North America Eye Drug by Country
5.1 North America Eye Drug Historic Market Size by Country
5.1.1 North America Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Eye Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Eye Drug Sales in Value by Country (2018-2024)
5.2 North America Eye Drug Forecasted Market Size by Country
5.2.1 North America Eye Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Eye Drug Sales in Value by Country (2024-2034)
6 Europe Eye Drug by Country
6.1 Europe Eye Drug Historic Market Size by Country
6.1.1 Europe Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Eye Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Eye Drug Sales in Value by Country (2018-2024)
6.2 Europe Eye Drug Forecasted Market Size by Country
6.2.1 Europe Eye Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Eye Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Eye Drug by Region
7.1 Asia-Pacific Eye Drug Historic Market Size by Region
7.1.1 Asia-Pacific Eye Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Eye Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Eye Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Eye Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Eye Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Eye Drug Sales in Value by Region (2024-2034)
8 Latin America Eye Drug by Country
8.1 Latin America Eye Drug Historic Market Size by Country
8.1.1 Latin America Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Eye Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Eye Drug Sales in Value by Country (2018-2024)
8.2 Latin America Eye Drug Forecasted Market Size by Country
8.2.1 Latin America Eye Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Eye Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Eye Drug by Country
9.1 Middle East and Africa Eye Drug Historic Market Size by Country
9.1.1 Middle East and Africa Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Eye Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Eye Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Eye Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Eye Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Eye Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Eye Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis Eye Drug Products Offered
10.2.5 Novartis Recent Development
10.3 bausch Lomb
10.3.1 bausch Lomb Company Information
10.3.2 bausch Lomb Introduction and Business Overview
10.3.3 bausch Lomb Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 bausch Lomb Eye Drug Products Offered
10.3.5 bausch Lomb Recent Development
10.4 Laboratoire Riva
10.4.1 Laboratoire Riva Company Information
10.4.2 Laboratoire Riva Introduction and Business Overview
10.4.3 Laboratoire Riva Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Laboratoire Riva Eye Drug Products Offered
10.4.5 Laboratoire Riva Recent Development
10.5 Jamp Pharma
10.5.1 Jamp Pharma Company Information
10.5.2 Jamp Pharma Introduction and Business Overview
10.5.3 Jamp Pharma Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Jamp Pharma Eye Drug Products Offered
10.5.5 Jamp Pharma Recent Development
10.6 Fresenius
10.6.1 Fresenius Company Information
10.6.2 Fresenius Introduction and Business Overview
10.6.3 Fresenius Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Fresenius Eye Drug Products Offered
10.6.5 Fresenius Recent Development
10.7 Teva Pharmaceutical?
10.7.1 Teva Pharmaceutical? Company Information
10.7.2 Teva Pharmaceutical? Introduction and Business Overview
10.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Pharmaceutical? Eye Drug Products Offered
10.7.5 Teva Pharmaceutical? Recent Development
10.8 SANDOZ
10.8.1 SANDOZ Company Information
10.8.2 SANDOZ Introduction and Business Overview
10.8.3 SANDOZ Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 SANDOZ Eye Drug Products Offered
10.8.5 SANDOZ Recent Development
10.9 Greenstone
10.9.1 Greenstone Company Information
10.9.2 Greenstone Introduction and Business Overview
10.9.3 Greenstone Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Greenstone Eye Drug Products Offered
10.9.5 Greenstone Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan Eye Drug Products Offered
10.10.5 Mylan Recent Development
10.11 GE Medical
10.11.1 GE Medical Company Information
10.11.2 GE Medical Introduction and Business Overview
10.11.3 GE Medical Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 GE Medical Eye Drug Products Offered
10.11.5 GE Medical Recent Development
10.12 Mint Pharmaceuticals
10.12.1 Mint Pharmaceuticals Company Information
10.12.2 Mint Pharmaceuticals Introduction and Business Overview
10.12.3 Mint Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Mint Pharmaceuticals Eye Drug Products Offered
10.12.5 Mint Pharmaceuticals Recent Development
10.13 Laboratoires Thea
10.13.1 Laboratoires Thea Company Information
10.13.2 Laboratoires Thea Introduction and Business Overview
10.13.3 Laboratoires Thea Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Laboratoires Thea Eye Drug Products Offered
10.13.5 Laboratoires Thea Recent Development
10.14 Taj Pharmaceuticals
10.14.1 Taj Pharmaceuticals Company Information
10.14.2 Taj Pharmaceuticals Introduction and Business Overview
10.14.3 Taj Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Taj Pharmaceuticals Eye Drug Products Offered
10.14.5 Taj Pharmaceuticals Recent Development
10.15 Actavis
10.15.1 Actavis Company Information
10.15.2 Actavis Introduction and Business Overview
10.15.3 Actavis Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Actavis Eye Drug Products Offered
10.15.5 Actavis Recent Development
10.16 APOTEX
10.16.1 APOTEX Company Information
10.16.2 APOTEX Introduction and Business Overview
10.16.3 APOTEX Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 APOTEX Eye Drug Products Offered
10.16.5 APOTEX Recent Development
10.17 Sun Pharma
10.17.1 Sun Pharma Company Information
10.17.2 Sun Pharma Introduction and Business Overview
10.17.3 Sun Pharma Eye Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Sun Pharma Eye Drug Products Offered
10.17.5 Sun Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Eye Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Eye Drug Industrial Chain Analysis
11.4 Eye Drug Market Dynamics
11.4.1 Eye Drug Industry Trends
11.4.2 Eye Drug Market Drivers
11.4.3 Eye Drug Market Challenges
11.4.4 Eye Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Eye Drug Distributors
12.3 Eye Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Drops
Table 2. Major Company of Tablet & Capsule
Table 3. Global Eye Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Eye Drug Sales by Type (2018-2024) & (MT)
Table 5. Global Eye Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Eye Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Eye Drug Market Share in Value by Type (2018-2024)
Table 8. Global Eye Drug Price by Type (2018-2024) & (USD/Kg)
Table 9. Global Eye Drug Sales by Type (2024-2034) & (MT)
Table 10. Global Eye Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Eye Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Eye Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Eye Drug Price by Type (2024-2034) & (USD/Kg)
Table 14. North America Eye Drug Sales by Type (2018-2024) & (MT)
Table 15. North America Eye Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Eye Drug Sales (MT) by Type (2018-2024)
Table 17. Europe Eye Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Eye Drug Sales (MT) by Type (2018-2024)
Table 19. Asia-Pacific Eye Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Eye Drug Sales (MT) by Type (2018-2024)
Table 21. Latin America Eye Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Eye Drug Sales (MT) by Type (2018-2024)
Table 23. Middle East and Africa Eye Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Eye Drug Sales by Company (2018-2024) & (MT)
Table 25. Global Eye Drug Sales Share by Company (2018-2024)
Table 26. Global Eye Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Eye Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Eye Drug Price by Company (2018-2024) & (USD/Kg)
Table 29. Global Eye Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eye Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Eye Drug Market
Table 33. Key Manufacturers Eye Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Eye Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Eye Drug Sales by Region (2018-2024) & (MT)
Table 37. Global Eye Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Eye Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Eye Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 41. Global Eye Drug Sales by Region (2024-2034) & (MT)
Table 42. Global Eye Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Eye Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Eye Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 46. Global Eye Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Eye Drug Sales by Application (2018-2024) & (MT)
Table 48. Global Eye Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Eye Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Eye Drug Price by Application (2018-2024) & (USD/Kg)
Table 52. Global Eye Drug Sales by Application (2024-2034) & (MT)
Table 53. Global Eye Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Eye Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Eye Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Eye Drug Price by Application (2024-2034) & (USD/Kg)
Table 57. North America Eye Drug Sales by Application (2018-2024) (MT)
Table 58. North America Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Eye Drug Sales by Application (2018-2024) (MT)
Table 60. Europe Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Eye Drug Sales by Application (2018-2024) (MT)
Table 62. Asia-Pacific Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Eye Drug Sales by Application (2018-2024) (MT)
Table 64. Latin America Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Eye Drug Sales by Application (2018-2024) (MT)
Table 66. Middle East and Africa Eye Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Eye Drug Sales by Country (2018-2024) & (MT)
Table 68. North America Eye Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Eye Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Eye Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Eye Drug Sales by Country (2024-2034) & (MT)
Table 72. North America Eye Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Eye Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Eye Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Eye Drug Sales by Country (2018-2024) & (MT)
Table 76. Europe Eye Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Eye Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Eye Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Eye Drug Sales by Country (2024-2034) & (MT)
Table 80. Europe Eye Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Eye Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Eye Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Eye Drug Sales by Region (2018-2024) & (MT)
Table 84. Asia-Pacific Eye Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Eye Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Eye Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Eye Drug Sales by Region (2024-2034) & (MT)
Table 88. Asia-Pacific Eye Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Eye Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Eye Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Eye Drug Sales by Country (2018-2024) & (MT)
Table 92. Latin America Eye Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Eye Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Eye Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Eye Drug Sales by Country (2024-2034) & (MT)
Table 96. Latin America Eye Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Eye Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Eye Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Eye Drug Sales by Country (2018-2024) & (MT)
Table 100. Middle East and Africa Eye Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Eye Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Eye Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Eye Drug Sales by Country (2024-2034) & (MT)
Table 104. Middle East and Africa Eye Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Eye Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Eye Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 110. Pfizer Eye Drug Product
Table 111. Pfizer Recent Development
Table 112. Novartis Company Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 115. Novartis Eye Drug Product
Table 116. Novartis Recent Development
Table 117. bausch Lomb Company Information
Table 118. bausch Lomb Introduction and Business Overview
Table 119. bausch Lomb Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 120. bausch Lomb Eye Drug Product
Table 121. bausch Lomb Recent Development
Table 122. Laboratoire Riva Company Information
Table 123. Laboratoire Riva Introduction and Business Overview
Table 124. Laboratoire Riva Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 125. Laboratoire Riva Eye Drug Product
Table 126. Laboratoire Riva Recent Development
Table 127. Jamp Pharma Company Information
Table 128. Jamp Pharma Introduction and Business Overview
Table 129. Jamp Pharma Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 130. Jamp Pharma Eye Drug Product
Table 131. Jamp Pharma Recent Development
Table 132. Fresenius Company Information
Table 133. Fresenius Introduction and Business Overview
Table 134. Fresenius Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 135. Fresenius Eye Drug Product
Table 136. Fresenius Recent Development
Table 137. Teva Pharmaceutical? Company Information
Table 138. Teva Pharmaceutical? Introduction and Business Overview
Table 139. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 140. Teva Pharmaceutical? Eye Drug Product
Table 141. Teva Pharmaceutical? Recent Development
Table 142. SANDOZ Company Information
Table 143. SANDOZ Introduction and Business Overview
Table 144. SANDOZ Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 145. SANDOZ Eye Drug Product
Table 146. SANDOZ Recent Development
Table 147. Greenstone Company Information
Table 148. Greenstone Introduction and Business Overview
Table 149. Greenstone Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 150. Greenstone Eye Drug Product
Table 151. Greenstone Recent Development
Table 152. Mylan Company Information
Table 153. Mylan Introduction and Business Overview
Table 154. Mylan Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 155. Mylan Eye Drug Product
Table 156. Mylan Recent Development
Table 157. GE Medical Company Information
Table 158. GE Medical Introduction and Business Overview
Table 159. GE Medical Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 160. GE Medical Eye Drug Product
Table 161. GE Medical Recent Development
Table 162. Mint Pharmaceuticals Company Information
Table 163. Mint Pharmaceuticals Introduction and Business Overview
Table 164. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 165. Mint Pharmaceuticals Eye Drug Product
Table 166. Mint Pharmaceuticals Recent Development
Table 167. Laboratoires Thea Company Information
Table 168. Laboratoires Thea Introduction and Business Overview
Table 169. Laboratoires Thea Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 170. Laboratoires Thea Eye Drug Product
Table 171. Laboratoires Thea Recent Development
Table 172. Taj Pharmaceuticals Company Information
Table 173. Taj Pharmaceuticals Introduction and Business Overview
Table 174. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 175. Taj Pharmaceuticals Eye Drug Product
Table 176. Taj Pharmaceuticals Recent Development
Table 177. Actavis Company Information
Table 178. Actavis Introduction and Business Overview
Table 179. Actavis Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 180. Actavis Eye Drug Product
Table 181. Actavis Recent Development
Table 182. APOTEX Company Information
Table 183. APOTEX Introduction and Business Overview
Table 184. APOTEX Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 185. APOTEX Eye Drug Product
Table 186. APOTEX Recent Development
Table 187. Sun Pharma Company Information
Table 188. Sun Pharma Introduction and Business Overview
Table 189. Sun Pharma Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 190. Sun Pharma Eye Drug Product
Table 191. Sun Pharma Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Eye Drug Market Trends
Table 195. Eye Drug Market Drivers
Table 196. Eye Drug Market Challenges
Table 197. Eye Drug Market Restraints
Table 198. Eye Drug Distributors List
Table 199. Eye Drug Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Eye Drug Product Picture
Figure 2. Global Eye Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Eye Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Eye Drug Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Drops
Figure 6. Global Drops Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Tablet & Capsule
Figure 8. Global Tablet & Capsule Sales YoY Growth (2018-2034) & (MT)
Figure 9. Global Eye Drug Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Eye Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Eye Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Eye Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Eye Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Eye Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Eye Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Eye Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Eye Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Eye Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Eye Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Eye Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Eye Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Eye Drug Revenue in 2022
Figure 23. Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Glaucoma
Figure 25. Global Glaucoma Sales YoY Growth (2018-2034) & (MT)
Figure 26. Product Picture of Retinal Disease
Figure 27. Global Retinal Disease Sales YoY Growth (2018-2034) & (MT)
Figure 28. Product Picture of Bacterial?Infection
Figure 29. Global Bacterial?Infection Sales YoY Growth (2018-2034) & (MT)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2034) & (MT)
Figure 32. Global Eye Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Eye Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Eye Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Eye Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Eye Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Eye Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Eye Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Eye Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Eye Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Eye Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Eye Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Eye Drug Manufacturing Cost Structure
Figure 45. Eye Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed